stockrowPhreesia, Inc. (PHR) vs SOPHiA GENETICS SA (SOPH)
- Phreesia, Inc. PHR 12.56 −1.18%
- SOPHiA GENETICS SA SOPH 7.09 +7.10%
Phreesia, Inc. and SOPHiA GENETICS SA are both Health Information Services companies. Phreesia, Inc. is the larger, with a market value of $788.9M against $563.6M — 1.4× the size. SOPHiA GENETICS SA has negative trailing earnings, so its P/E is not meaningful; Phreesia, Inc. trades at 74.4×. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 24.1% against 12.9%. Phreesia, Inc. has the higher net margin (2.06% vs −89.2%) and the higher return on invested capital (1.74% vs −200.9%). Across the 18 metrics below, Phreesia, Inc. leads on 15 and SOPHiA GENETICS SA on 3.
Valuation
Profitability
| Metric | PHR | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 67.52% | 66.43% | 59.61% |
| Operating margin | 2.47% | (80.99%) | (10.54%) |
| Net margin | 2.06% | (89.18%) | (16.14%) |
| Free cash flow margin | 13.30% | (45.64%) | 0.00% |
| Return on equity | 3.12% | (125.67%) | (3.15%) |
| Return on assets | 1.98% | (46.60%) | (5.62%) |
| Return on invested capital | 1.74% | (200.89%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack